April 29, 2024
Reporter, Health Care Inc. Writer
Hello! On May 21, I’ll be on a webinar hosted by the Association of Health Care Journalists and Investigative Reporters and Editors. It’s all about the hidden financial incentives within health insurance and pharmacy benefits companies. I’ll be joined by Chris Hamby of the New York Times (who wrote the recent investigation into MultiPlan) and Joe Burns of AHCJ. Register for free here. And as always, let me know if there’s anything on your mind: bob.herman@statnews.com.

regulation

Will nonprofit hospitals get a pass on noncompetes?
AdobeStock_268207004

Adobe

No news was bigger last week than the Federal Trade Commission’s ban on noncompete agreements. If implemented, it would upend the competitive landscape between nonprofit and for-profit hospitals. That’s because the agency acknowledged — to the chagrin of at least one commissioner — that its power doesn’t extend to nonprofits, my colleague Tara Bannow reports.

However, there may be some wiggle room. The FTC estimated that “some portion” of the 58% of tax-exempt hospitals and the 19% of government hospitals likely fall under the final rule if they behave like for-profits (*blank stare*). 

Large, wealthy nonprofit health systems have long been criticized for acting like for-profits. Ascension runs a Wall Street-style private equity fund. CommonSpirit Health paid its CEO $35 million in 2021. Some big systems essentially have their own earnings calls. But to actually make nonprofit hospitals subject to the noncompete ban, someone would have to sue, kicking off a “long, arduous process,” Robert Slavkin, a health care attorney at the law firm Akerman, told Tara.

Of course, all of this might be moot. Multiple lawsuits argue the FTC overstepped its authority. We are, realistically, years away from this being resolved. But the rule has at least forced companies to think differently about how they employ people. As Slavkin told Tara: “These types of steps forward — the good, the bad, and the ugly — have an effect on the way things are done.”


insurance

MultiPlanning on more legal costs

MultiPlan is facing a new class action lawsuit — initiated by a for-profit hospital company called Allegiance Health Management — that alleges MultiPlan and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims.

The lawsuit comes just weeks after the aforementioned Hamby of the NYT published an in-depth report about how MultiPlan and its insurance company clients operate. Before that story, a different hospital system, AdventHealth, had launched the first big legal assault on MultiPlan.

These lawsuits are (allegedly) exposing both how insurers profit by low-balling payments for out-of-network care, but also how some providers believe they have an unquestioned right to collect inflated amounts if they don’t participate in insurance networks. Patients, meanwhile, are stuck in the middle with bills they often cannot afford. Read more to understand the lawsuit and its allegations, see which insurers are getting roped in with MultiPlan, and get a small taste of what Allegiance is.


medicaid

When Medicaid rates go commercial

Hospitals and other providers love to gripe about Medicaid because they claim the program pays the least of any insurance program out there. Well, except for when it pays like commercial health plans.

The Biden administration finalized a host of Medicaid rules last week, and there is one provision that is an absolute boon for hospitals. It involves what’s known as “state directed payments.” Essentially, these arrangements allow states and their managed Medicaid insurance companies to increase payment rates for certain providers, such as safety net hospitals that treat high numbers of poor people. The Government Accountability Office said these directed payments cost $38.5 billion total in 2022, and the Medicaid and CHIP Payment and Access Commission has raised concerns about their lack of transparency. 

The final rule allows state Medicaid programs to boost directed payments to hospitals and nursing homes as long as they do “not exceed the average commercial rate,” which the government vaguely defined as the “average rate paid for services by the highest claiming third-party payers for specific services as measured by claims volume.” In other words, the Centers for Medicare and Medicaid Services just signed off on some Medicaid payments being on par with employer-based health insurance price tags (and we know commercial prices are extremely problematic).

“If you allow states to pay hospitals’ average commercial rates, you’ve just given [hospitals] another reason to keep raising their average commercial rates,” said Ann Kempski, an independent health policy consultant with more than two decades of experience studying hospitals, Medicaid, and payment policies. “This is what the CMS people don’t seem to understand — they just turbocharged what was already a crazy commercial hospital pricing game out there.”



unitedhealth

Witty’s $25 million payday

Proxy season can be extremely entertaining. You really get to see the ways corporate America throws money at the C-suite — like how the chairman of the pest control company Rollins was reimbursed $142,000 last year just for the “use of executive dining room” (flagged by Louis Ashworth of the Financial Times). 

Health care has no shortage of colossal compensation figures. And one of the biggest health care companies, UnitedHealth Group, just laid out how much its top brass made: CEO Andrew Witty, who will face Congress this week over the Change Healthcare cyberattack, collected $25 million in 2023 based on the actual realized gains of his stock. Witty’s top lieutenants, CFO John Rex and President Dirk McMahon, also took home eight-figure paydays. 

(Also, in case you were wondering, UnitedHealth still did not disclose in the proxy filing that its board chair, Stephen Hemsley, runs his own investment firm.)


hospitals

Piping-hot merger literature

Are you a nerd who enjoys journal articles and the effects of hospital mergers? Well, you’re in luck. Tara and I are nerds, too, and we dug into two such studies out last week.

The first: We can no longer assume that “cross-market” mergers, in which the combining hospital systems are located far apart, are harmless. Those deals still lead to higher prices for everyone. Read more from Tara

The second: A large number of hospital mergers have escaped Federal Trade Commission scrutiny, which has led to huge spikes in prices and spending — and this has happened largely because the FTC doesn’t have enough resources to stop anticompetitive deals. Read more from me.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Industry odds and ends

  • My colleague Ed Silverman spotted that Johnson & Johnson filed a motion to dismiss the lawsuit that alleges it overpaid for its workers’ medicines and failed in its role as a fiduciary. J&J did not throw its pharmacy benefit manager or benefits consultant under the bus (yet), according to the filing, and instead said the employee who filed the lawsuit lacked standing. For a refresher on the case, read this from Ed and me.
  • Health care interest groups — especially those representing pharmacy benefit managers, physicians, and hospitals — rang up huge lobbying bills in the first quarter of this year, my colleague Rachel Cohrs Zhang reports.
  • Unions in Connecticut have attempted to sue Elevance Health for allegedly blocking access to their claims data and overpaying providers with their money. They now have two months to file a new complaint after a judge partially allowed Elevance’s motion to dismiss the case. The judge was not convinced that Elevance is a fiduciary, under the federal law ERISA.
  • Indiana University Health released first-quarter financials, among the first tax-exempt hospital systems to do so. The results: slim operating margin (0.7%), but huge investment gains led to a big total margin (14.1%).
  • OptumRx is ending its drug distribution contract with Cardinal Health and shifting its business to McKesson. The switch will cost Cardinal roughly $30 billion of revenue, which led to Wall Street selling off its stock last week.
  • Some patients, especially those who are homeless or struggle with addiction, essentially live in the emergency room. It’s a costly issue, and the Tradeoffs podcast goes deep with the Camden Coalition, the famous medical group in New Jersey, to understand what lessons can be gleaned from the past two decades of trying to help those people out.

The Meme Ward

Health Care Inc. Meme - Issue 92


Thanks for reading! More next week. 


Enjoying Health Care Inc.? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.